| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 44.571 | 69.499 | 93.521 | 84.257 | 80.940 | 48.376 | 68.604 | 74.509 | - | - |
| Total Income - EUR | 44.622 | 69.499 | 93.521 | 84.257 | 80.940 | 48.376 | 68.604 | 74.509 | - | - |
| Total Expenses - EUR | 17.164 | 18.610 | 21.740 | 20.291 | 20.858 | 17.725 | 16.860 | 20.512 | - | - |
| Gross Profit/Loss - EUR | 27.457 | 50.890 | 71.781 | 63.966 | 60.082 | 30.651 | 51.744 | 53.996 | - | - |
| Net Profit/Loss - EUR | 26.120 | 48.804 | 68.975 | 61.439 | 57.654 | 29.297 | 49.727 | 51.806 | - | - |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
Check the financial reports for the company - R&B Med Clinique Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 11 | 984 | 1.202 | 6.497 | 24.312 | 18.318 | 12.384 | 4.546 | - | - |
| Current Assets | 26.545 | 48.913 | 68.540 | 60.173 | 33.956 | 13.060 | 78.187 | 49.300 | - | - |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 120 | - | - |
| Receivables | 655 | 1.400 | 3.129 | 49.925 | 16.814 | 9.374 | 40.513 | 46.518 | - | - |
| Cash | 25.890 | 47.513 | 65.411 | 10.248 | 17.142 | 3.686 | 37.674 | 2.662 | - | - |
| Shareholders Funds | 26.174 | 48.858 | 69.028 | 61.854 | 57.705 | 29.454 | 49.902 | 51.981 | - | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 149 | 146 | 146 | - | - |
| Debts | 382 | 1.039 | 786 | 4.816 | 619 | 2.131 | 40.858 | 1.865 | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - R&B Med Clinique Srl